Skip to main content

LianBio

LIANY
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001831283

No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in LianBio as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
36
−4 vs. Q4 2022
Shares held
80.2M
−1.07M (−1.3%) vs. Q4 2022
Total value
$157.1M
+$23.8M (+17.9%) vs. Q4 2022
New holders
4
6 more added
Sold out
8
9 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 36 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 36 institutionsQ1 2022: 37 institutionsQ2 2022: 44 institutionsQ3 2022: 44 institutionsQ4 2022: 40 institutionsQ1 2023: 36 institutionsQ2 2023: 39 institutionsQ3 2023: 38 institutionsQ4 2023: 29 institutionsQ1 2024: 3 institutionsQ2 2024: 2 institutionsQ3 2024: 2 institutionsQ4 2024: 2 institutionsQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2023: $157.1M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $550.5MQ1 2022: $318.6MQ2 2022: $187.1MQ3 2022: $168.0MQ4 2022: $133.3MQ1 2023: $157.1MQ2 2023: $182.9MQ3 2023: $117.7MQ4 2023: $377.3MQ1 2024: $49.2KQ2 2024: $50.5KQ3 2024: $47.3KQ4 2024: $42.1KQ1 2025: $2.00KQ2 2025: $5.00KQ3 2025: $0Q4 2025: $1.00KQ1 2026: $1.00KQ2 2026: $1.00K
Institutions holding LIANY and their total value by quarter
QuarterHoldersValue
Q2 20261$1.00K
Q1 20261$1.00K
Q4 20251$1.00K
Q3 20251$0
Q2 20251$5.00K
Q1 20251$2.00K
Q4 20242$42.1K
Q3 20242$47.3K
Q2 20242$50.5K
Q1 20243$49.2K
Q4 202329$377.3M
Q3 202338$117.7M
Q2 202339$182.9M
Q1 202336$157.1M
Q4 202240$133.3M
Q3 202244$168.0M
Q2 202244$187.1M
Q1 202237$318.6M
Q4 202136$550.5M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q4 2022.

Institutions holding LIANY in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Perceptive Advisors LLC57,558,451$112.8M3.34%00.0%Unchanged
Cormorant Asset Management, LP4,250,000$8.33M0.55%+4,250,000New
Viking Global Investors LPSuperinvestorViking Global Investors3,564,173$6.95M0.03%00.0%Unchanged
Tybourne Capital Management (HK) Ltd3,303,573$6.48M0.65%00.0%Unchanged
Price T Rowe Associates Inc2,537,609$4.95M0.00%−143,888−5.4%Reduced
Vida Ventures Advisors, LLC2,282,084$4.47M6.12%00.0%Unchanged
Wellington Management Group LLP1,032,084$2.01M0.00%00.0%Unchanged
BlackRock Inc.1,023,107$2.01M0.00%00.0%Unchanged
SCHF (Gpe), LLC937,500$1.84M3.24%00.0%Unchanged
Citigroup Inc723,636$1.41M0.00%+16,300+2.3%Added
Affinity Asset Advisors, LLC650,000$1.27M0.49%00.0%Unchanged
Renaissance Technologies LLC296,200$581.0K0.00%+5,578+1.9%Added
Logos Global Management LP280,000$548.8K0.08%00.0%Unchanged
Millennium Management LLC251,495$490.0K0.00%−69,023−21.5%Reduced
Tang Capital Management LLC209,600$410.8K0.06%+150,000+251.7%Added
Casdin Capital, LLC206,415$402.5K0.03%00.0%Unchanged
TD Asset Management Inc178,519$348.1K0.00%00.0%Unchanged
Cornercap Investment Counsel Inc165,400$324.2K0.06%−318−0.2%Reduced
22NW, LP141,223$276.8K0.18%00.0%Unchanged
MYDA Advisors LLC120,000$235.2K0.10%−15,000−11.1%Reduced
Manufacturers Life Insurance Company, The117,484$229.1K0.00%00.0%Unchanged
Citadel Advisors LLC111,762$217.9K0.00%−30,431−21.4%Reduced
Barclays PLC62,269$122.0K0.00%−66,459−51.6%Reduced
HighTower Advisors, LLC34,500$68.0K0.00%−14,000−28.9%Reduced
Old Well Partners, LLC32,200$63.1K0.05%00.0%Unchanged
Vident Investment Advisory, LLC27,778$54.4K0.00%−838−2.9%Reduced
Jane Street Group, LLC26,381$51.7K0.00%−21,202−44.6%Reduced
Stifel Financial Corp23,534$46.1K0.00%+2,284+10.7%Added
Geode Capital Management, LLC15,494$30.2K0.00%+15,494New
Commonwealth Equity Services, LLC13,830$27.0K0.00%+3,000+27.7%Added
Bank of America Corp12,783$25.1K0.00%+251+2.0%Added
Susquehanna International Group, LLP12,536$24.4K0.00%+12,536New
Psagot Value Holdings Ltd. / (Israel)1,678$3.00K0.00%+1,678New
Morgan Stanley1,001$1.96K0.00%00.0%Unchanged
Cary Street Partner Investment Advisory LLC1,000$1.96K0.00%00.0%Unchanged
Royal Bank of Canada10$00.00%00.0%Unchanged
VR Adviser, LLC0$00.00%−4,793,047−100.0%Sold out
Innovis Asset Management LLC0$00.00%−176,192−100.0%Sold out
Thrivent Financial for Lutherans0$00.00%−81,168−100.0%Sold out
Victory Capital Management Inc0$00.00%−64,506−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−19,482−100.0%Sold out
Virtu Financial LLC0$00.00%−17,456−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−8,519−100.0%Sold out
UBS Group AG0$00.00%−4,024−100.0%Sold out